The new Chief Business Development Officer is focused on driving ESTEVE's growth to enhance value for people's lives.

ESTEVE has announced the appointment of Jacob Tolstrup as Chief Business Development Officer, part of the Executive Management and reporting to Staffan Schüberg, Chief Executive Officer of ESTEVE.

Jacob Tolstrup has held positions that provided him with a holistic understanding of the business, including Corporate Functions comprising Business Strategy and Development, Marketing, Human Resources, Investor Relations, Corporate Communications, IT and Finance. Before joining ESTEVE, he held the position of Executive Vice President of Commercial Operations at Lundbeck. Tolstrup's academic background includes an MSc in Business Administration and Commercial Law and an MBA in International Management.

With his understanding of the pharmaceutical landscape and track record of success, Tolstrup is positioned to support ESTEVE's strategic path: to become a leading international specialty pharmaceutical company. This includes both organic and inorganic growth through acquisitions of companies or products, to become a company that truly adds differential value to people's lives.

Staffan Schüberg, Chief Executive Officer of ESTEVE, stated that "Jacob will bring extensive experience in Business Development and strategic acumen during an important moment for ESTEVE. His background and expertise make him an ideal fit for our company as we advance ESTEVE's strategic goals with the purpose of improving people's lives.".

For his part, Jacob Tolstrup stated "Joining ESTEVE at this transformative juncture is both a significant challenge and a profound responsibility. I am enthusiastic about the chance to play a role in shaping ESTEVE's future as the company is now embarking on a new business model that will redefine its position in the pharmaceutical landscape".